Nephrology Virtual Congress News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights
Over 250 patient start forms received by the end of the first quarter – – Cash and cash equivalents, and investments of $360.9 million at March 31, 2021 – – Conference call to be hosted today at 5:00 p.m. ET – Aurinia Pharmaceuticals Inc. today issued its financial results for the first quarter ended March 31, 2021. Amounts, unless specified otherwise, are expressed in U.S. dollars. “2021 started with the FDA …
– Over 250 patient start forms received by the end of the first quarter –
– Cash and cash equivalents, and investments of $360.9 million at March 31, 2021
–
– Conference call to be hosted today at 5:00 p.m. ET – ....

United States , United Kingdom , Max Colao , Peter Greenleaf , Glenn Schulman , Dana Lynch , European Congress , Nephrology Virtual Congress , Contract Research Organization , Aurinia Pharmaceuticals Inc , Exchange Commission Electronic Document Gathering , Aurinia Alliance , Corporate Communications , European Medicines Agency , Aurinia Pharmaceuticals , Company Quarterly Report On Form , Patient Marketing Campaign , Chief Executive Officer , Commercial Launch , Marketing Campaign , Chief Commercial Officer , Annual European Congress , Quarter Ended March , Quarterly Report , British Columbia , Annual Report ,